Long-term anticoagulation and selective cells adhesion surface via combination of covalent grafting and layer by layer assembly.

Biomed Mater

Key Laboratory of Textile Science and Technology of Ministry of Education and College of Textiles, Donghua University, 2999 North Renmin Road, Shanghai 201620, People's Republic of China.

Published: October 2019

Surface modification by long-term active component is essential for biocompatible polymers-based vascular grafts to prevent thrombus formation and reduce intimal hyperplasia. In this study, a simple approach was developed to immobilize bioactive heparin to the surface of ε-polycaprolactone (PCL) grafts through a two-step strategy combining covalent grafting and layer by layer assembly of polyelectrolytes. The performance of heparinized PCL was evaluated in vitro, including the release behavior of heparin, anticoagulation and different types of cells adhesion characteristic. A sustained-release of heparin was achieved by this immobilization strategy. Surface remaining heparin was up to 1.10 μg cm on the modified PCL after release in vitro for 30 d. Specifically, the heparinized PCL has the long-term ability to prevent adhesion of blood cells and thrombus formation, and significantly inhibit the adhesion of smooth muscle cells. The two-step strategy provides a simple and general route to incorporate heparin on PCL graft surface. The surface heparinized PCL demonstrated in this work can be a useful material platform for biodegradable vascular stent graft.

Download full-text PDF

Source
http://dx.doi.org/10.1088/1748-605X/ab452bDOI Listing

Publication Analysis

Top Keywords

heparinized pcl
12
cells adhesion
8
covalent grafting
8
grafting layer
8
layer layer
8
layer assembly
8
thrombus formation
8
two-step strategy
8
surface
6
pcl
6

Similar Publications

The Efficacy of Heparin and Nitroglycerin in Managing Vascular Embolism Complications from Polycaprolactone (PCL) Fillers: A Clinical Study.

Aesthetic Plast Surg

January 2025

Department of Plastic and Cosmetic Surgery, Tongji Hospital, School of Medicine, Tongji University, No.389 Xincun Road, Shanghai, 200092, China.

Background: The use of PCL fillers has increased due to their long-lasting effects and collagen stimulation properties. However, managing vascular embolisms caused by PCL fillers is challenging due to the inability to dissolve them quickly. This study builds upon our previous findings from animal studies, which provided valuable insights into the management of PCL-related vascular complications.

View Article and Find Full Text PDF

Zero-Order Kinetics Release of Lamivudine from Layer-by-Layer Coated Macromolecular Prodrug Particles.

Int J Mol Sci

December 2024

Department of Physical Chemistry and Biophysics, Pharmaceutical Faculty, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland.

To reduce the risk of side effects and enhance therapeutic efficiency, drug delivery systems that offer precise control over active ingredient release while minimizing burst effects are considered advantageous. In this study, a novel approach for the controlled release of lamivudine (LV) was explored through the fabrication of polyelectrolyte-coated microparticles. LV was covalently attached to poly(ε-caprolactone) via ring-opening polymerization, resulting in a macromolecular prodrug (LV-PCL) with a hydrolytic release mechanism.

View Article and Find Full Text PDF

Application of subcutaneous extracellular matrix to prepare bilayer heparin-coated polycaprolactone/decellularized small-diameter vascular graft for tissue regeneration.

Int J Biol Macromol

December 2024

Department of Vascular Surgery, Xuan Wu Hospital and Institute of Vascular Surgery, Capital Medical University, Beijing 100053,China. Electronic address:

In clinical practice, the demand for functional small-diameter vascular grafts continues to increase. In this study, a decellularized aorta artery was inserted into a poly(caprolactone) (PCL) vascular scaffold for self-assembly in-vitro to create a hybrid scaffold. The hybrid scaffold was then implanted subcutaneously into the dorsal flanks and the subcutaneous extracellular matrix was applied for bilayer adhesion.

View Article and Find Full Text PDF

The main objective of this study is to construct radially aligned PCL nanofibers reinforced with levan polymer and investigate their in vitro biological activities thoroughly. First Halomonas levan (HL) polysaccharide is hydrolyzed (hHL) and subjected to sulfation to attain Sulfated hydrolyzed Halomonas levan (ShHL)-based material indicating heparin mimetic properties. Then, optimization studies are carried out to produce coaxially generated radially aligned Poly(caprolactone) (PCL) -ShHL nanofibers via electrospinning.

View Article and Find Full Text PDF

Inflammation-responsive PCL/gelatin microfiber scaffold with sustained nitric oxide generation and heparin release for blood-contacting implants.

Int J Biol Macromol

November 2024

State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, China. Electronic address:

Article Synopsis
  • * A new microfiber scaffold is designed to address these issues using various biocompatible materials, including PCL and heparin, which help prevent protein adsorption and blood cell adhesion, reducing the risk of thrombosis.
  • * The scaffold also employs an inflammation-responsive compound to detoxify harmful reactive oxygen species and control inflammation, demonstrating improved blood compatibility and potential for successful use in blood-contacting implants.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!